IPCALAB.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 12:00):

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India...

Stats
Tagesvolumen	196 709
Durchschnittsvolumen	566 151
Marktkapitalisierung	339.58B
EPS	INR0 ( 2024-02-13 )
Nächstes Ertragsdatum	( INR5.60 ) 2024-05-27
Last Dividend	INR4.00 ( 2022-11-22 )
Next Dividend	INR0 ( N/A )
P/E	60.29
ATR14	INR1.871 (0.14%)

Volumen Korrelation

Lang: 0.04 (neutral)

Kurz: 0.87 (strong)

Signal:(42.068) Same movement expected

Ipca Laboratories Limited Korrelation

10 Am meisten positiv korreliert
ALLCARGO.NS	0.878
RAJVIR.NS	0.838
AJRINFRA.NS	0.808
KHAITANLTD.NS	0.801

10 Am meisten negativ korreliert
FOCUS.NS	-0.833
AGI.NS	-0.82
BANCOINDIA.NS	-0.816
KOVAI.NS	-0.812
MAYURUNIQ.NS	-0.81
MEGH.NS	-0.804
HILTON.NS	-0.804
FINCABLES.NS	-0.802
BECTORFOOD.NS	-0.802
SUPERHOUSE.NS	-0.802

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Ipca Laboratories Limited Korrelation - Währung/Rohstoff

-0.20
( neutral )

-0.54
( weak negative )

-0.49
( neutral )

-0.22
( neutral )

0.18
( neutral )

0.32
( neutral )

Ipca Laboratories Limited Finanzdaten

Annual	2022
Umsatz:	INR62.44B
Bruttogewinn:	INR39.38B (63.06 %)
EPS:	INR18.58

FY	2022
Umsatz:	INR62.44B
Bruttogewinn:	INR39.38B (63.06 %)
EPS:	INR18.58

FY	2022
Umsatz:	INR57.66B
Bruttogewinn:	INR36.60B (63.48 %)
EPS:	INR34.85

FY	2021
Umsatz:	INR53.41B
Bruttogewinn:	INR35.39B (66.27 %)
EPS:	INR45.01

Financial Reports:

No articles found.

Ipca Laboratories Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR4.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Ipca Laboratories Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.59 - low (19.38%) | Divividend Growth Potential Score: 1.866 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.150	1999-11-24
Last Dividend	INR4.00	2022-11-22
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	40	--
Total Paid Out	INR32.15	--
Avg. Dividend % Per Year	0.20%	--
Score	1.8	--
Div. Sustainability Score	3.59
Div.Growth Potential Score	1.866
Div. Directional Score	2.73	--

Next Divdend (Est)
(2024-05-06)

INR0 Estimate 0.00 %

Dividend Stability

0.08 Very Bad

Dividend Score

1.80

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
1999	INR0	0.00%
2000	INR0	0.00%
2001	INR0	0.00%
2002	INR0	0.00%
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0.500	0.14%
2019	INR1.500	0.37%
2020	INR6.50	1.14%
2021	INR4.00	0.37%
2022	INR4.00	0.37%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
PUNJABCHEM.NS	Dividend Junior	2023-07-27	Sporadic	18	0.16%
KENNAMET.NS	Dividend Knight	2023-05-25	Annually	4	0.76%
ELECTCAST.NS	Dividend Junior	2023-09-04	Annually	23	1.51%
AHLUCONT.NS	Dividend Junior	2023-09-22	Sporadic	15	0.04%
SUNPHARMA.NS	Dividend Junior	2023-07-28	Semi-Annually	29	0.77%
NAVA.NS	Dividend Knight	2023-07-24	Annually	23	2.35%
HONAUT.NS	Dividend Junior	2023-08-03	Annually	21	0.15%
CARBORUNIV.NS	Dividend Junior	2023-07-25	Semi-Annually	23	0.33%
ROHLTD.NS	Dividend Junior	2023-09-15	Sporadic	19	0.20%
LAURUSLABS.NS	Dividend Knight	2023-05-10	Semi-Annually	8	0.35%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0785	1.500	8.43	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.126	1.500	9.71	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	7.15	1.000	8.46	8.46	[3 - 30]
operatingCashFlowPerShareTTM	25.91	2.00	1.364	2.73	[0 - 30]
freeCashFlowPerShareTTM	25.91	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.655	1.000	2.42	2.42	[0.2 - 0.8]
operatingProfitMarginTTM	0.127	1.000	9.47	9.47	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.59

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	60.18	1.000	4.02	0	[1 - 100]
returnOnEquityTTM	0.126	2.50	9.81	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	25.91	2.00	1.364	10.00	[0 - 30]
dividendYielPercentageTTM	0.149	1.500	6.26	0	[0 - 0.4]
operatingCashFlowPerShareTTM	25.91	2.00	1.364	2.73	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.289	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0915	1.000	-0.213	0	[0.1 - 0.5]
Total Score				1.866

Ipca Laboratories Limited

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.